Brief: Bal Pharma approves allotment of 1.3 mln shares on preferential basis

Bal Pharma

13/04/2016 11:30

April 13 (Reuters) - Bal Pharma Ltd  BALP.NS : 
 * Approved allotment of 1.3 million shares on preferential basis to investors 
   who have exercised conversion option on 1.3 million warrants 
 
 * Source text: Bal Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 13, 2016, inter alia, has approved the allotment of 13,00,000 equity shares of Rs. 10/- each with a premium of Rs. 52/- per share of the Company on preferential basis to the investors who has exercised the conversion option on 13,00,000 warrants subscribed by them. 
 
With this allotment, the paid up equity share capital of the Company has enhanced to Rs. 14,17,23,720/- divided into 1,41,72,372 equity shares of Rs. 10 each. 
 
 * Further company coverage  BALP.NS   
 
   ((Bengaluru Newsroom; +91 80 6749 1130))